Illinois SB 3222: What the New Hemp Safety Law Means for Medical Cannabis Patients
Illinois hemp safety law SB 3222 restricts intoxicating hemp sales to those under 21 and expands medical cannabis access through telehealth and curbside pickup. The law aims to improve patient safety and streamline access. However, real-world…
CED Cannabis Science Digest: 3 Road Safety, Edible Toxicity, and Pain Biomarker Signals
This digest presents cannabis road safety signals, edible toxicity insights, and pain biomarker findings. Each signal offers valuable information for clinicians and patients. Understanding these signals is crucial for informed discussions about cannabis…
Cannabis Science Evidence Report: Pediatric Coma, Cannabinoid Ingestion, and Urine Toxicology Screening
This report discusses pediatric cannabinoid ingestion screening. It highlights the importance of rapid urine screening in cases of pediatric coma. The findings emphasize the need for cautious interpretation of results.
Cannabis and Working Memory: Brain Imaging Study Explains Cognitive Impact
The 2026 cannabis working memory study highlights significant findings on cognitive effects. It shows how cannabis use correlates with reduced brain activity in working memory tasks. Understanding these implications is crucial for patient counseling and…
CED Cannabis Science Digest: 3 Behavior, CBD, and Formulation Signals Worth Watching
Today's standalone pediatric safety report captured the strongest signal from the scan. This digest preserves three additional verified lower-certainty papers worth watching: a Bangkok mixed-method study on cannabis and sexual-health behavior context, a…
U.S. Child Cannabis Exposures Through 2024: What the New Poison Center Study Shows
A June 26, 2026 Journal of Addiction Medicine study found that cannabis exposures reported to U.S. poison centers rose sharply in children age 12 and under from 2009 through 2024. The signal is clinically important for prevention and counseling, but the…
Cannabinoids and Mental Health: Insights from 54 Trials
The cannabinoids mental health evidence review highlights findings from 54 randomized trials. This analysis shows no significant benefits for cannabinoids in treating anxiety, PTSD, or depression. Understanding these results is crucial for informed…
CED Cannabis Science Digest: 3 Mental Health, Prenatal, and Oncology Caution Signals
This digest highlights 2026 cannabis prenatal safety signals focusing on mental health risks, prenatal placental evidence, and oncology pilot trial insights. These signals guide clinical caution without overstating treatment claims. They sharpen…
Best Marijuana Vape Pen 2026: Top Cannabis Devices Reviewed
This article highlights the best marijuana vape pen 2026, reviewing top cannabis vaporization devices. Clinicians can gain insights into current cannabis administration methods. These findings inform patient counseling and clinical relevance.
Cannabis Science Full Report: What a Five-Year Low Back Pain Cannabis Cohort Can and Cannot Tell Us
A five-year medical-cannabis cohort study in chronic low back pain reported large improvements, but its uncontrolled design requires careful interpretation.
